Showing 1 - 3 results of 3 for search 'the Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee', query time: 0.03s Refine Results
  1. 1
    Developing lay summaries and thank you notes in paediatric pragmatic clinical trials

    Developing lay summaries and thank you notes in paediatric pragmatic clinical trials by Kanecia O. Zimmerman, Brian Perry, Emily Hanlen‐Rosado, Adora Nsonwu, Morgan D. Lane, Daniel K. Benjamin, Mara Becker, Amy Corneli, Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population

    Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population by Elizabeth J. Thompson, Angela Jeong, Victória E. Helfer, Valentina Shakhnovich, Andrea Edginton, Stephen J. Balevic, Laura P. James, David N. Collier, Ravinder Anand, Daniel Gonzalez, the Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee

    Published 2024-08-01
    Get full text
    Article
  3. 3
    Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity

    Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity by Jacqueline G. Gerhart, Fernando O. Carreño, Jennifer L. Ford, Andrea N. Edginton, Eliana M. Perrin, Kevin M. Watt, William J. Muller, Andrew M. Atz, Amira Al‐Uzri, Paula Delmore, Daniel Gonzalez, Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee

    Published 2022-06-01
    Get full text
    Article

Search Tools: